• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Glutaraldehyde cross-linked bovine casein microspheres as a matrix for the controlled release of theophylline: in-vitro studies.

作者信息

Latha M S, Jayakrishnan A

机构信息

Polymer Chemistry Division, Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum, India.

出版信息

J Pharm Pharmacol. 1994 Jan;46(1):8-13. doi: 10.1111/j.2042-7158.1994.tb03711.x.

DOI:10.1111/j.2042-7158.1994.tb03711.x
PMID:8201534
Abstract

A controlled release dosage form of theophylline in the form of microspheres using the milk protein casein as the matrix is described. Glutaraldehyde cross-linking of an aqueous alkaline solution of the protein containing the drug, dispersed in a mixture of dichloromethane/hexane having ca. 1% of an aliphatic polyurethane as the suspension stabilizer, led to the formation of the drug-loaded microspheres. Drug incorporation efficiency of around 80% could be achieved by the technique. Release profiles of the drug were examined in simulated gastric and intestinal fluids at 37 degrees C. It was observed that the release was diffusion-controlled and followed the Higuchi model. Release characteristics were influenced by the cross-linking density, particle size and the extent of loading. Data obtained indicate that the natural milk protein casein could be used as a matrix for sustained release oral dosage forms.

摘要

相似文献

1
Glutaraldehyde cross-linked bovine casein microspheres as a matrix for the controlled release of theophylline: in-vitro studies.
J Pharm Pharmacol. 1994 Jan;46(1):8-13. doi: 10.1111/j.2042-7158.1994.tb03711.x.
2
Progesterone release from glutaraldehyde cross-linked casein microspheres: in vitro studies and in vivo response in rabbits.
Contraception. 2000 May;61(5):329-34. doi: 10.1016/s0010-7824(00)00113-x.
3
Evaluation of an aliphatic polyurethane as a microsphere matrix for sustained theophylline delivery.评估一种脂肪族聚氨酯作为用于持续释放茶碱的微球基质。
J Microencapsul. 1995 Nov-Dec;12(6):617-25. doi: 10.3109/02652049509006792.
4
Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.交联壳聚糖微球:作为药物控释基质的制备与评价
J Pharm Pharmacol. 1992 Apr;44(4):283-6. doi: 10.1111/j.2042-7158.1992.tb03607.x.
5
Controlled release of oral drugs from cross-linked polyvinyl alcohol microspheres.
J Pharm Pharmacol. 1993 Jan;45(1):16-20. doi: 10.1111/j.2042-7158.1993.tb03671.x.
6
Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.戊二醛交联壳聚糖微球用于齐多夫定的控制释放。
J Microencapsul. 2009 May;26(3):214-22. doi: 10.1080/02652040802246325.
7
Formation and in-vitro evaluation of theophylline-loaded poly(methyl methacrylate) microspheres.
J Pharm Pharmacol. 1988 Aug;40(8):530-3. doi: 10.1111/j.2042-7158.1988.tb05296.x.
8
Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.阿那曲唑载壳聚糖微球的缓释优化配方:体外与体内评价。
J Mater Sci Mater Med. 2011 Apr;22(4):865-78. doi: 10.1007/s10856-011-4274-y. Epub 2011 Mar 23.
9
Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.用于炔诺酮肟控释的戊二醛和乙二醛交联壳聚糖微球
Carbohydr Res. 2006 May 1;341(6):744-56. doi: 10.1016/j.carres.2006.02.003. Epub 2006 Feb 24.
10
Preparation and properties of glutaraldehyde cross-linked whey protein-based microcapsules containing theophylline.
J Control Release. 1999 Aug 27;61(1-2):123-36. doi: 10.1016/s0168-3659(99)00108-x.

引用本文的文献

1
Preparation and characterization of homogeneous and enhanced casein protein-based composite films via incorporating cellulose microgel.通过添加纤维素微凝胶制备和表征均一且增强的酪蛋白基复合薄膜。
Sci Rep. 2019 Feb 4;9(1):1221. doi: 10.1038/s41598-018-37848-1.